tiprankstipranks
Trending News
More News >
Sectra AB Class B (SE:SECT.B)
:SECT.B

Sectra AB Class B (SECT.B) AI Stock Analysis

Compare
2 Followers

Top Page

SE:SECT.B

Sectra AB Class B

(SECT.B)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
kr196.00
▼(-21.73% Downside)
Action:ReiteratedDate:12/18/25
Sectra AB Class B's overall stock score is primarily supported by its strong financial performance, characterized by high profitability and low leverage. However, the technical analysis indicates bearish momentum, and the high P/E ratio suggests potential overvaluation, which negatively impacts the score.
Positive Factors
High Profitability
Sectra's exceptionally high gross margin and robust net margin indicate durable product-level economics and pricing power typical of software-heavy medical solutions. Sustained margins support R&D, recurring service delivery, and long-term profitability even if revenue growth moderates.
Very Low Leverage
Minimal leverage gives Sectra financial flexibility to fund product development, pursue selective M&A, and weather healthcare spending cycles without heavy interest burdens. High ROE shows efficient capital use, supporting sustainable shareholder returns and resilience over 2-6 months.
Recurring Revenue Model
A revenue mix weighted to software licensing, maintenance contracts and services creates predictable, recurring cash flows and high client retention typical in healthcare IT. That visibility improves planning, smooths revenue volatility and underpins long-term margin stability.
Negative Factors
Slowing Revenue Growth
Decelerating top-line expansion can limit scale benefits for fixed-cost absorption and slow market-share gains in imaging and cybersecurity. If growth remains muted, investment returns and long-term earnings expansion may be constrained despite strong margins and balance sheet strength.
Declining Free Cash Flow Growth
An 11.7% drop in FCF growth reduces available internal funding for R&D, acquisitions, or shareholder returns. Persisting declines could force trade-offs between reinvestment and capital returns, weakening the company's ability to execute strategic initiatives over the medium term.
OCF Coverage Below 1
Operating cash flow covering only 71% of net income suggests earnings are not fully converting to cash, possibly from working capital or timing effects. If structural, this can constrain liquidity for growth and increase sensitivity to invoice timing or contract renewals over coming quarters.

Sectra AB Class B (SECT.B) vs. iShares MSCI Sweden ETF (EWD)

Sectra AB Class B Business Overview & Revenue Model

Company DescriptionSectra AB Class B (SECT.B) is a Swedish company specializing in medical technology and cybersecurity solutions. It operates primarily in the healthcare sector, offering products and services that enhance medical imaging, radiology, and pathology. Sectra's core offerings include advanced imaging software for radiology and breast imaging, as well as solutions for managing and sharing medical images securely. Additionally, the company provides cybersecurity solutions for protecting sensitive information within the healthcare sector.
How the Company Makes MoneySectra generates revenue through a combination of software licensing, maintenance contracts, and professional services related to its medical imaging and cybersecurity solutions. Key revenue streams include recurring revenues from long-term contracts with healthcare providers for software maintenance and support, as well as one-time sales from new software licenses and equipment. The company also benefits from partnerships with healthcare organizations and technology providers, which can enhance its market reach and provide tailored solutions to clients. Additionally, Sectra's focus on innovation in imaging technology and cybersecurity helps to secure ongoing demand for its products and services.

Sectra AB Class B Financial Statement Overview

Summary
Sectra AB Class B exhibits strong financial health with high profitability, low leverage, and effective cash flow management. While revenue growth has slowed, the company maintains robust margins and a solid balance sheet. The decline in free cash flow growth warrants attention, but overall, the financial position is stable and well-managed.
Income Statement
85
Very Positive
Sectra AB Class B demonstrates strong profitability with a high gross profit margin of 89.05% TTM, indicating efficient cost management. The net profit margin of 17.85% TTM is robust, reflecting solid bottom-line performance. Revenue growth is positive at 2.96% TTM, although it shows a deceleration compared to previous periods. EBIT and EBITDA margins remain healthy at 22.61% and 26.05% TTM, respectively, showcasing operational efficiency.
Balance Sheet
90
Very Positive
The company's balance sheet is strong, characterized by a low debt-to-equity ratio of 0.047 TTM, indicating minimal leverage and financial risk. Return on equity is impressive at 32.06% TTM, highlighting effective use of shareholder funds. The equity ratio stands at a solid level, reflecting a stable capital structure.
Cash Flow
75
Positive
Operating cash flow is robust, with a coverage ratio of 0.71 TTM, indicating good cash generation relative to net income. However, free cash flow growth has declined by 11.73% TTM, which could signal potential challenges in cash flow management. The free cash flow to net income ratio remains strong at 0.91 TTM, suggesting efficient conversion of profits into cash.
BreakdownTTMApr 2024Apr 2023Apr 2022Apr 2021Apr 2020
Income Statement
Total Revenue3.38B3.24B2.96B2.35B1.95B1.63B
Gross Profit2.45B543.41M557.55M488.91M1.71B1.48B
EBITDA922.34M795.35M615.06M538.55M477.28M429.01M
Net Income646.40M563.37M428.39M374.96M314.79M275.51M
Balance Sheet
Total Assets3.50B3.76B3.21B2.74B2.19B1.65B
Cash, Cash Equivalents and Short-Term Investments1.02B1.34B804.64M945.24M808.77M454.85M
Total Debt95.09M87.46M31.79M82.26M62.62M73.45M
Total Liabilities1.71B1.84B1.64B1.44B1.11B756.33M
Stockholders Equity1.79B1.92B1.57B1.30B1.08B895.62M
Cash Flow
Free Cash Flow881.89M812.37M75.58M347.70M542.55M304.53M
Operating Cash Flow962.59M922.36M326.33M440.49M616.92M372.19M
Investing Cash Flow-113.86M-113.86M-130.74M-212.79M-68.35M-66.82M
Financing Cash Flow-447.62M-251.88M-222.20M-219.29M-198.75M-198.69M

Sectra AB Class B Technical Analysis

Technical Analysis Sentiment
Negative
Last Price250.40
Price Trends
50DMA
228.62
Negative
100DMA
262.38
Negative
200DMA
298.31
Negative
Market Momentum
MACD
-14.11
Negative
RSI
32.44
Neutral
STOCH
36.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SECT.B, the sentiment is Negative. The current price of 250.4 is above the 20-day moving average (MA) of 201.92, above the 50-day MA of 228.62, and below the 200-day MA of 298.31, indicating a bearish trend. The MACD of -14.11 indicates Negative momentum. The RSI at 32.44 is Neutral, neither overbought nor oversold. The STOCH value of 36.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SECT.B.

Sectra AB Class B Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
kr3.53B23.0317.89%1.61%1.53%0.79%
60
Neutral
kr5.69B232.101.32%8.39%-85.36%
58
Neutral
kr35.26B53.8638.97%0.43%10.08%68.12%
57
Neutral
kr54.77B24.266.91%2.16%6.74%21.40%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
kr1.27B-1.12-57.26%-23.24%45.32%
49
Neutral
kr11.96B-2.463.34%0.80%-1.29%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:SECT.B
Sectra AB Class B
188.00
-50.76
-21.26%
SE:GETI.B
Getinge
203.60
-12.74
-5.89%
SE:VITR
Vitrolife AB
90.65
-106.89
-54.11%
SE:BICO
BICO Group AB Class B
18.42
-21.60
-53.97%
SE:CEVI
CellaVision AB
155.20
-26.29
-14.49%
SE:XVIVO
Xvivo Perfusion AB
189.10
-263.40
-58.21%

Sectra AB Class B Corporate Events

Sectra Reports Strong Growth and Profitability in H1 2025/2026
Dec 12, 2025

Sectra reported significant growth in order bookings, sales, and profitability for the first half of 2025/2026, driven by high customer satisfaction and market expansion in North America. The company’s strong financial performance, highlighted by increased recurring and cloud revenues, underscores its strengthened market position and operational efficiency.

The most recent analyst rating on ($SE:SECT.B) stock is a Hold with a SEK321.00 price target. To see the full list of analyst forecasts on Sectra AB Class B stock, see the SE:SECT.B Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025